Cited by 1,010Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 142 of the 146 references it cites were found in a registry or an index.

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

Wild, Robert A., Carmina, Enrico, Diamanti-Kandarakis, Evanthia, Dokras, Anuja, Escobar-Morreale, Hector F., Futterweit, Walter, Lobo, Rogerio, Norman, Robert J., Talbott, Evelyn, Dumesic, Daniel A.·2010·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jc.2009-2724

Open this paper in CoChat — free account

Abstract

OBJECTIVE: Women with polycystic ovary syndrome (PCOS) often have cardiovascular disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society created a panel to provide evidence-based reviews of studies assessing PCOS-CVD risk relationships and to develop guidelines for preventing CVD. PARTICIPANTS: An expert panel in PCOS and CVD reviewed literature and presented recommendations. EVIDENCE: Only studies comparing PCOS with control patients were included. All electronic databases were searched; reviews included individual studies/databases, systematic reviews, abstracts, and expert data. Articles were excluded if other hyperandrogenic disorders were not excluded, PCOS diagnosis was unclear, controls were not described, or methodology precluded evaluation. Inclusion/exclusion criteria were confirmed by at least two reviewers and arbitrated by a third. CONSENSUS PROCESS: Systematic reviews of CVD risk factors were compiled and submitted for approval to the AE-PCOS Society Board. CONCLUSIONS: Women with PCOS with obesity, cigarette smoking, dyslipidemia, hypertension, impaired glucose tolerance, and subclinical vascular disease are at risk, whereas those with metabolic syndrome and/or type 2 diabetes mellitus are at high risk for CVD. Body mass index, waist circumference, serum lipid/glucose, and blood pressure determinations are recommended for all women with PCOS, as is oral glucose tolerance testing in those with obesity, advanced age, personal history of gestational diabetes, or family history of type 2 diabetes mellitus. Mood disorder assessment is suggested in all PCOS patients. Lifestyle management is recommended for primary CVD prevention, targeting low-density and non-high-density lipoprotein cholesterol and adding insulin-sensitizing and other drugs if dyslipidemia or other risk factors persist.

Integrity signals

Registry

Crossref · 10.1210/jc.2009-2724

Cites

142 of 142 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Withdrawn: Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome Evaluation
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
Retracted
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“In two large intervention studies, almost 60% relative risk reduction in conversion to diabetes mellitus occurred in obese individuals (BMI, 30 kg/ m(2)) with IGT randomized to intensive lifestyle modification to reduce body weight by 5–7% (101, 102); less dramatic improvement occurred in less obese individuals (BMI,…”
Background
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Bariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457

Show all 146 references

Research works printed but not linked: 1

Zawadki, 1992, Diagnostic criteria for polycystic ovary syndrome: towards a rational approach, In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications;, 377

Sorted by citations

Items 501–600 of 1,000

The Molecular Basis of Polycystic Ovary Syndrome and Its Cardiometabolic Correlates: Exploring the Intersection and Its Clinical Implications—A Narrative Review
Mahabamunuge, J., Sekula, N. M., Lepore, C., Kudrimoti, M., Upadhyay, A., Alshowaikh, K., Li, H. J., Seifer, D. B., & AlAshqar, A. (2025) · Biomedicines · doi:10.3390/biomedicines13030709 · Cited by 23
Expression of the plasminogen system in the physiological mouse ovary and in the pathological polycystic ovary syndrome (PCOS) state
Burchall, G., Pouniotis, D. S., Teede, H. J., Ranasinha, S., Walters, K. A., & Piva, T. J. (2019) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0472-0 · Cited by 16
Heterogeneity of Endocrinologic and Metabolic Parameters in Reproductive Age Polycystic Ovary Syndrome (PCOS) Women Concerning the Severity of Hyperandrogenemia—A New Insight on Syndrome Pathogenesis
Ożegowska, K., Korman, M., Szmyt, A., & Pawelczyk, L. A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17249291 · Cited by 18
An overview of polycystic ovary syndrome in aging women
Çelik, Ö., & Köse, M. F. (2021) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.galenos.2021.2021.0077 · Cited by 16
Need to Introduce the Finding of Obesity or Normal Body Weight in the Current Diagnostic Criteria and in the Classification of PCOS
Carmina, E. (2022) · Diagnostics · doi:10.3390/diagnostics12102555 · Cited by 16
Self-citation
Effects of distinct Polycystic Ovary Syndrome phenotypes on bone health
Mills, E., Abbara, A., Dhillo, W. S., & Comninos, A. N. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1163771 · Cited by 18
Short- and long-term safety and efficacy of bariatric surgery for severely obese adolescents: a narrative review
Sarno, L. A., Lipshultz, S. E., Harmon, C. M., Cruz-Munoz, N. F. D. L., & Balakrishnan, P. L. (2019) · Pediatric Research · doi:10.1038/s41390-019-0532-3 · Cited by 17
A Review on Phytomedicine and Their Mechanism of Action on PCOS
Pachiappan, S., Ramalingam, K., & Balasubramanian, A. (2020) · International Journal of Current Research and Review · doi:10.31782/ijcrr.2020.122322 · Cited by 16
Analysis of the vascular responses in a murine model of polycystic ovary syndrome
Labruijere, S., van Houten, E. L. A. F., VRIES, R. D., Bhaggoe, U. M., Garrelds, I. M., Kramer, P., Danser, A. H. J., Villalón, C. M., Visser, J. A., & MaassenVanDenBrink, A. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0094 · Cited by 16
Cardiometabolic risk in patients with polycystic ovary syndrome.
Ozegowska, K., & Pawelczyk, L. (2015) · Polish Gynaecology · doi:10.17772/gp/59131 · Cited by 15
Circulating apelin and chemerin levels in patients with polycystic ovary syndrome: A meta-analysis
Gao, Y., Xin, C., Fan, H., Sun, X., & Wang, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1076951 · Cited by 15
Longitudinal prospective cohort study evaluating prognosis in idiopathic intracranial hypertension patients with and without comorbid polycystic ovarian syndrome
Thaller, M., Homer, V., Sassani, M., Mollan, S. P., & Sinclair, A. J. (2023) · Eye · doi:10.1038/s41433-023-02569-x · Cited by 17
Female-Specific Factors for IHD: Across the Reproductive Lifespan
SHUFELT, C. L., Waldman, T., Wang, E. T., & Merz, C. N. B. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0481-6 · Cited by 15
Should we individualize lipid profiling in women with polycystic ovary syndrome?
Poromaa, I. S., Mellembakken, J. R., Morin-Papunen, L. C., Piltonen, T., Puurunen, J., Tapanainen, J. S., Stener‐Victorin, E., Hirschberg, A. L., Vanky, E., Ravn, P., et al. (2016) · Human Reproduction · doi:10.1093/humrep/dew228 · Cited by 15
Lifestyle Interventions for Polycystic Ovary Syndrome: Cross-Sectional Survey to Assess Women's Treatment and Outcome Preferences
Saslow, L. R., & Aikens, J. E. (2020) · JMIR Formative Research · doi:10.2196/17126 · Cited by 15
The expression of platelet-derived growth factor, epidermal growth factor, and insulin-like growth factor-II in patients with polycystic ovary syndrome and its correlation with pregnancy outcomes
Gao, J., Song, Y., Huang, X. L., Wang, D., & Wang, H. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-1003 · Cited by 15
Hemostatic Abnormalities and Relationships to Metabolic and Hormonal Status in Polycystic Ovarian Syndrome
Burchall, G., Linden, M. D., Teede, H. J., & Piva, T. J. (2011) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.01.001 · Cited by 15
Heart rate variability in normal-weight patients with polycystic ovary syndrome
Kılıt, C. (2017) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2017.7473 · Cited by 15
Cardiovascular Risk in Postmenopausal Women with Polycystic Ovary Syndrome
Armeni, E., & Lambrinoudaki, I. V. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161116666180828154006 · Cited by 15
Serum and follicular fluid irisin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with insulin resistance and lipoprotein lipid profiles
Bousmpoula, A., Benidis, E., Demeridou, S., Kapeta-Kourkouli, R., Chasiakou, A., Chasiakou, S., Kouskouni, E. E., & Baka, S. G. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1594761 · Cited by 15
Polycystic ovary syndrome: Metabolic consequences and long-term management
Carmina, E. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2014.936676 · Cited by 15
Self-citation
Characteristics of polycystic ovary syndrome rat models induced by letrozole, testosterone propionate and high-fat diets
Hu, R., Huang, Y., Liu, Z., Dong, H., Ma, W., Song, K., Xu, X., Wu, X. W., Geng, Y., Li, F., et al. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.104296 · Cited by 16
Practice Patterns in Screening for Metabolic Disease in Women with PCOS of Diverse Race-Ethnic Backgrounds
Mott, M. M., Kitos, N. R., & Coviello, A. D. (2014) · Endocrine Practice · doi:10.4158/ep13414.or · Cited by 14
Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome
Çelik, E., Türkçüoğlu, İ., Ata, B., Karaer, A., Kirici, P., Eraslan, S., Taşkapan, Ç., & Berker, B. (2016) · Journal of the Turkish-German Gynecological Association · doi:10.5152/jtgga.2016.16133 · Cited by 14
No. 350-Hirsutism: Evaluation and Treatment
Liu, K. E., Motan, T., & Claman, P. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.05.022 · Cited by 14
Avaliação do risco cardiovascular por meio do índice LAP em pacientes não obesas com síndrome dos ovários policísticos
Costa, E. C., de Sá, J. C. F., Soares, E. M. M., Lemos, T. M. A. M., Maranhão, T. M. D. O., & Azevedo, G. D. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000700007 · Cited by 14
CYP19 gene expression in subcutaneous adipose tissue is associated with blood pressure in women with polycystic ovary syndrome
Lecke, S. B., Morsch, D. M., & Spritzer, P. M. (2011) · Steroids · doi:10.1016/j.steroids.2011.07.008 · Cited by 14
Influence of peroxisome proliferator-activated receptor-γ exon 2 and exon 6 and insulin receptor substrate (IRS)-1 Gly972Arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome
Giandalia, A., Pappalardo, M. A., Russo, G. T., Romeo, E. L., Alibrandi, A., Bari, F. D., Vita, R., Cucinotta, D., & Benvenga, S. (2018) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2018.05.002 · Cited by 14
New insights into the interaction between polycystic ovary syndrome and psychiatric disorders: A narrative review
Hu, R., Geng, Y., Huang, Y., Liu, Z., Li, F., Dong, H., Ma, W., Song, K., Zhang, M., Zhang, Z., et al. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14988 · Cited by 15
Exploring female infertility: A comprehensive review of polycystic ovary syndrome (PCOS) and its impact on reproductive health
Parua, S., Purkait, M. P., Bhattacharjee, A., Thangarajan, R., Subramanian, R., Islam, K., Bhattacharya, K., & Syamal, A. K. (2025) · Obesity Medicine · doi:10.1016/j.obmed.2025.100619 · Cited by 17
Hypertriglyceridemic waist is associated with impaired glucose tolerance in polycystic ovary syndrome
Lerchbaum, E., Schwetz, V., Giuliani, A., & Obermayer-Pietsch, B. M. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.11.004 · Cited by 13
Polymorphisms of TCF7L2 gene in South Brazilian women with polycystic ovary syndrome: a cross-sectional study
Ramos, R. B., Wiltgen, D., & Spritzer, P. M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0105 · Cited by 13
Ultrasound assessment of polycystic ovaries: Ovarian volume and morphology; which is more accurate in making the diagnosis?!
Ibrahim, H., Elsadawy, M. E. I., & Khater, N. H. (2015) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1016/j.ejrnm.2015.10.002 · Cited by 13
Polycystic ovary syndrome and metabolic syndrome: the worrisome twosome?
Shah, D., & Rasool, S. (2015) · Climacteric · doi:10.3109/13697137.2015.1116505 · Cited by 13
Polycystic Ovary Syndrome
Goetsch, A. L., Kimelman, D., & Woodruff, T. K. (2017) · Springer eBooks · doi:10.1007/978-3-319-52316-3_14 · Cited by 14
Fibroblast growth factor 23 and 25(OH)D levels are related to abdominal obesity and cardiovascular risk in patients with polycystic ovarian syndrome
Gateva, A., Tsakova, A. D., Hristova, J., & Kamenov, Z. A. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1689550 · Cited by 13
Lipid-induced mononuclear cell cytokine secretion in the development of metabolic aberration and androgen excess in polycystic ovary syndrome
González, F., Considine, R. V., Abdelhadi, O. A., & Acton, A. J. (2020) · Human Reproduction · doi:10.1093/humrep/deaa056 · Cited by 13
Efficacy of simvastatin plus metformin for polycystic ovary syndrome: A meta-analysis of randomized controlled trials
Meng, J., & Zhu, Y. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.11.070 · Cited by 13
Astragaloside IV regulates autophagy-mediated proliferation and apoptosis in a rat model of PCOS by activating the PPARγ pathway.
Wen, M., Chen, W., Zhou, Q. Y., & Dou, X. (2022) · PubMed Central · doi:10.22038/ijbms.2022.64475.14179 · Cited by 13
The effect of prolactin levels on MPV in women with PCOS
Yılmaz, Ö., Çalan, M., Küme, T., Temür, M., Yesil, P., & Senses, Y. M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12647 · Cited by 13
Models and Mechanisms of Metabolic Regulation: Genes, Stress, and the HPA and HPG Axes
Boersma, G. J., Salton, S. R., Spritzer, P. M., Steele, C. T., & Carbone, D. L. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0032-1311576 · Cited by 13
Lipoprotein profiles in Mexican American and non-Hispanic white women with polycystic ovary syndrome
Kauffman, R. P., Baker, T. E., Graves-Evenson, K., Baker, V. M., & Castracane, V. D. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.025 · Cited by 13
Female Genomics: Infertility and Overall Health
Joshi, N., & Chan, J. L. (2017) · Seminars in Reproductive Medicine · doi:10.1055/s-0037-1603095 · Cited by 13
The Role of Androgen Excess in Metabolic Dysfunction in Women
Escobar-Morreale, H. F. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_26 · Cited by 13
Self-citation
The impact of polycystic ovary syndrome on women’s quality of life: Nursing guidelines for its
Hassan, H. E., & Farag, D. S. S. (2019) · Clinical Nursing Studies · doi:10.5430/cns.v7n3p42 · Cited by 13
Body Mass Index below Obesity Threshold Implies Similar Cardiovascular Risk among Various Polycystic Ovary Syndrome Phenotypes
Bağır, G. Ş., Bakıner, O., Bozkırlı, E., Cavlak, G., Serinsöz, H., & Ertörer, M. E. (2015) · Medical Principles and Practice · doi:10.1159/000440810 · Cited by 13
POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Long-term health outcomes in polycystic ovary syndrome
Dokras, A., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2025) · Reproduction · doi:10.1530/rep-25-0118 · Cited by 12
Self-citation
Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women
Tang, L., Xu, L., Pan, X., Zhang, J., Wu, T., & Liu, G. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008583 · Cited by 12
Gonadal dysfunction in morbidly obese adolescent girls
Chin, V. L., Censani, M., Lerner, S. E., Conroy, R., Oberfield, S. E., McMahon, D. J., Zitsman, J. L., & Fennoy, I. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.12.046 · Cited by 12
Androgens and polycystic ovary syndrome
Alpañés, M., Fernández‐Durán, E., & Escobar-Morreale, H. F. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.85 · Cited by 12
Self-citation
Hyperinsulinemia and obese phenotype differently influence blood pressure in young normotensive patients with polycystic ovary syndrome
Mioni, R., Cà, A. D., Turra, J., Azzolini, S., Xamin, N., Bleve, L., Maffei, P., Vettor, R., & Fallo, F. (2016) · Endocrine · doi:10.1007/s12020-016-0958-x · Cited by 12
Resolvin D1 impacts on insulin resistance in women with polycystic ovary syndrome and healthy women
Morshedzadeh, N., Saedisomeolia, A., Djalali, M., Eshraghian, M. R., Hantoushzadeh, S., & Mahmoudi, M. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.11.018 · Cited by 12
Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women
Zhang, J., Tang, L., Kong, L., Wu, T., Xu, L., Pan, X., & Liu, G. J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008583.pub2 · Cited by 11
Application of proteomics to the study of polycystic ovary syndrome.
Insenser, M. R., & Escobar-Morreale, H. F. (2011) · PubMed · doi:10.3275/8108 · Cited by 12
Self-citation
Glucose and lipopolysaccharide regulate proatherogenic cytokine release from mononuclear cells in polycystic ovary syndrome
González, F., Kirwan, J. P., Rote, N. S., Minium, J., & O’Leary, V. B. (2014) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2014.01.001 · Cited by 12
Clinical Variability in Cardiovascular Disease Risk Factor Screening and Management in Adolescent and Young Adult Women with Polycystic Ovary Syndrome
Baer, T. E., Milliren, C. E., Walls, C. E., & DiVasta, A. D. (2014) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2014.09.010 · Cited by 12
The Influence of Dietary Patterns on Polycystic Ovary Syndrome Management in Women: A Review of Randomized Controlled Trials with and Without an Isocaloric Dietary Design
Choi, Y.-J., Kang, K., Je, M., Lee, Y., & Kim, Y. (2025) · Nutrients · doi:10.3390/nu17040674 · Cited by 15
Sexual Dimorphism in Cardiometabolic Diseases: From Development to Senescence and Therapeutic Approaches
Chevalley, T., Dübi, M., Fumeaux, L., Merli, M. S., Sarre, A., Schaer, N., Siméoni, U., & Yzydorczyk, C. (2025) · Cells · doi:10.3390/cells14060467 · Cited by 13
Polycystic ovary syndrome and diabetes screening: a survey of gynecologists and reproductive endocrinologists
Abdel-Rahman, M., Jackson, L. W., Rodewald, K. J., Abdellah, M. A., Ismail, S. A., & Hurd, W. W. (2012) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2012.03.007 · Cited by 11
Decreased deiodinase activity after glucose load could lead to atherosclerosis in euthyroid women with polycystic ovary syndrome
Adamska, A., Krentowska, A., Łebkowska, A., Hryniewicka, J., Leśniewska, M., Adamski, M., & Kowalska, I. (2019) · Endocrine · doi:10.1007/s12020-019-01913-0 · Cited by 11
A safety evaluation of current medications for adult women with the polycystic ovarian syndrome not pursuing pregnancy
Luque‐Ramírez, M., Ortiz-Flores, A. E., Nattero‐Chávez, L., & Escobar-Morreale, H. F. (2020) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2020.1839409 · Cited by 11
Self-citation
Association between rs7903146 and rs12255372 polymorphisms of transcription factor 7-like 2 gene and polycystic ovary syndrome: a systematic review and meta-analysis
Ramos, R. B., Fabris, V. C., Brondani, L. D. A., & Spritzer, P. M. (2015) · Endocrine · doi:10.1007/s12020-015-0541-x · Cited by 11
Assessment of the body composition of patients with polycystic ovary syndrome using dual‐energy X‐ray absorptiometry
Macruz, C. F., Lima, S. M. R. R., Salles, J. E. N., da Silva, G. M. D., & Scalissi, N. M. (2017) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12066 · Cited by 11
The Role of C-Peptide as Marker of Cardiometabolic Risk in Women With Polycystic Ovary Syndrome: A Controlled Study
de Medeiros, S. F., Angelo, L. C. A., de Medeiros, M. A. S., Banhara, C. R., Barbosa, B. B., & Yamamoto, M. M. W. (2018) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3325w · Cited by 11
Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
Alalami, H., Sathyapalan, T., & Atkin, S. L. (2018) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818805674 · Cited by 12
Is copeptin a new potential biomarker of insulin resistance in polycystic ovary syndrome?
Widecka, J., Ożegowska, K., Banaszewska, B., Kazienko, A., Safranow, K., Branecka‍-Woźniak, D., Pawelczyk, L. A., & Kurzawa, R. (2019) · Ginekologia Polska · doi:10.5603/gp.2019.0021 · Cited by 13
Impact of an online multicomponent very-low-carbohydrate program in women with polycystic ovary syndrome: a pilot study
Missel, A. L., O’Brien, A., MASER, H., Kanwal, A., Bayandorian, H., Martin, S., Carrigan, P., McNamee, R., Daubenmier, J. J., Isaman, D. J. M., et al. (2021) · F&S Reports · doi:10.1016/j.xfre.2021.08.008 · Cited by 12
Gastric bypass surgery in women with or without polycystic ovary syndrome—A comparative observational cohort analysis
Kyriacou, A., Hunter, L., Tolofari, S., & Syed, A. A. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.09.012 · Cited by 11
GENOME-WIDE MAPPING
Kang, S. W. (2013) · Apple Academic Press eBooks · doi:10.1201/b14910-12 · Cited by 23
GLP-1 receptor agonists and preconception planning: bridging the gap between obesity treatment and reproductive safety, a narrative review
Alfaiz, A. S. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000004189 · Cited by 10
Heat Therapy: Targeting Health, Disease, and Disability
Richey, R. E., Hyldahl, R. D., Kaiser, B. W., Geiger, P. C., Halliwill, J. R., & Minson, C. T. (2026) · Comprehensive physiology · doi:10.1002/cph4.70089 · Cited by 11
Guideline No. 444: Hirsutism: Evaluation and Treatment
Elliott, J., Liu, K. E., & Motan, T. (2023) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2023.102272 · Cited by 13
Effects of interleukin-1 receptor antagonism in women with polycystic ovary syndrome—the FertIL trial
Popovic, M., Monnerat, S., TAYLOR, A. E. R., Gilligan, L. C., Schiffer, L., Arlt, W., Vogt, D., Geyter, C. D., Hutter, N., Donath, M. Y., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1435698 · Cited by 12
Measures of Serum Markers HbA1c, HOMA-IR, HOMA-β, QUICKI and G/I Ratio as Predictors of Abnormal Glucose Tolerance Among Thai Women with Polycystic Ovary Syndrome
Wongwananuruk, T., Prasongvej, P., Chantrapanichkul, P., Indhavivadhana, S., Tanmahasamut, P., Rattanachaiyanont, M., Techatraisak, K., & Angsuwathana, S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051452 · Cited by 12
Inflammatory status and clinical phenotypes of PCOS: the role of NLR, SII, SIRI, and AISI
Özkan, H. D., Özkan, M. A., Dayanan, R., Bulan, D. D., Filiz, A. A., & Üstün, Y. E. (2025) · BMC Women s Health · doi:10.1186/s12905-025-04033-2 · Cited by 11
Faster thrombin generation in women with polycystic ovary syndrome compared with healthy controls matched for age and body mass index
de Mendonça-Louzeiro, M. R. M. F., Annichino‐Bizzacchi, J. M., Magna, L. A., Quaino, S. K. P., & Benetti‐Pinto, C. L. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.01.105 · Cited by 10
Prevalence of Polycystic Ovarian Syndrome, Phenotypes and their Ovulation Response to Sequential Letrozole Dose Escalation among Infertile Women at a Tertiary Care Centre in Southern India
Khurana, A., Swamy, M., Mitra, S., Srinivas, S., & Nagaraja, N. (2022) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_141_21 · Cited by 11
Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome
Paterakis, T., & Diamanti‐Kandarakis, E. (2014) · Current Obesity Reports · doi:10.1007/s13679-014-0127-6 · Cited by 10
Self-citation
Is the Risk for Cardiovascular Disease Increased in all Phenotypes of the Polycystic Ovary Syndrome?
Daskalopoulos, G. N., Karkanaki, A., Karagiannis, A. I., Mikhailidis, D. P., & Athyros, V. G. (2011) · Angiology · doi:10.1177/0003319711399571 · Cited by 10
Relationship between flavonoids intake and metabolic syndrome in Korean women with polycystic ovary syndrome
Oh, J. S., Ahn, M. J., Han, C. J., Kim, H., Kwon, O., Chung, H. W., & Chang, N. (2014) · Journal of Nutrition and Health · doi:10.4163/jnh.2014.47.3.176 · Cited by 10
Women’s Health Considerations for Lipid Management
Wild, R. A., Weedin, E. A., & Gill, E. A. (2015) · Cardiology Clinics · doi:10.1016/j.ccl.2015.02.003 · Cited by 10
Self-citation
Plasma Von Willebrand factor antigen levels are elevated in the classic phenotypes of polycystic ovary syndrome
Koiou, E., Τζιόμαλος, Κ., Katsikis, I., Dinas, K. D., Tsourdi, E. A., Kandaraki, E., Delkos, D., Papadakis, E. P., & Panidis, D. (2012) · HORMONES · doi:10.1007/bf03401540 · Cited by 10
Metabolic and Hormonal Profile of Adolescent Girls With Polycystic Ovary Syndrome With Concomitant Autoimmune Thyroiditis
Skrzyńska, K., Zachurzok, A., & Gawlik, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.708910 · Cited by 10
Long-Term Health Outcomes of Korean Adults With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Lim, S. G., Lee, Y. A., Jang, H. N., Kong, S. H., Ahn, C. H., Kim, S. W., Shin, C. H., & Kim, J. H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.761258 · Cited by 10
Evidence of mononuclear cell preactivation in the fasting state in polycystic ovary syndrome
González, F., Kirwan, J. P., Rote, N. S., & Minium, J. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.06.044 · Cited by 10
Genetic variations in SREBP-1 and LXRα are not directly associated to PCOS but contribute to the physiological specifics of the syndrome
Knebel, B., Janssen, O. E., Hahn, S., Jacob, S., Nitzgen, U., Haas, J., Müller‐Wieland, D., & Kotzka, J. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1508-0 · Cited by 10
Fertility biomarkers to estimate metabolic risks in women with polycystic ovary syndrome
Detti, L., Jeffries-Boyd, H. E., Williams, L. J., Diamond, M. P., & Uhlmann, R. A. (2015) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-015-0602-3 · Cited by 10
Pulses and Prevention and Management of Chronic Disease
Kazemi, M., Buddemeyer, S., Fassett, C. M., Gans, W. M., Johnston, K., Lungu, E., Savelle, R. L., Tolani, P. N., & Dahl, W. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-12763-3_5 · Cited by 10
Letrozole induced a polycystic ovary syndrome model in zebrafish by interfering with the hypothalamic-pituitary-gonadal axis
Zhang, F., Tang, C., Wang, J., Lin, T., Ge, W., He, C., Yang, C., & Zuo, Z. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.123723 · Cited by 9
Cardiovascular disease in polycystic ovary syndrome*
Atkin, S. L. (2013) · Clinical Endocrinology · doi:10.1111/cen.12151 · Cited by 9
Maternal self-reported polycystic ovary syndrome with offspring and maternal cardiometabolic outcomes
Polinski, K. J., Robinson, S. L., Putnick, D. L., Sundaram, R., Ghassabian, A., Joseph, P. V., Gomez‐Lobo, V., Bell, E. M., & Yeung, E. H. (2023) · Human Reproduction · doi:10.1093/humrep/dead227 · Cited by 9
Cardiac fatty acid uptake and metabolism in the rat model of polycystic ovary syndrome
Tepavčević, S., Milutinović, D. V., Μacut, D., Stojiljković, M., Nikolič, M., Antić, I. B., Ćulafić, T., Bjekić-Macut, J., Matić, G. M., & Korićanac, G. (2015) · Endocrine · doi:10.1007/s12020-015-0558-1 · Cited by 9
Android fat distribution affects some hemostatic parameters in women with polycystic ovary syndrome compared with healthy control subjects matched for age and body mass index
de Mendonça-Louzeiro, M. R. M. F., Annichino‐Bizzacchi, J. M., & Benetti‐Pinto, C. L. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.05.013 · Cited by 9
Insulin and Testosterone are Associated with Elevated Intestinal Secretion of Lipids and Lipoproteins in a Rodent Model of the Metabolic and Polycystic Ovary Syndrome
(2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000391 · Cited by 9
Pharmacologic Treatments for PCOS Patients
Kodama, S., & Torrealday, S. (2020) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000597 · Cited by 10
Artificial Intelligence in Diagnosis of Polycystic Ovarian Syndrome
Roy, D. G., & Alvi, P. A. (2021) · Lecture notes in networks and systems · doi:10.1007/978-981-16-4244-9_37 · Cited by 9
Screening for dysglycaemia by oral glucose tolerance test should be recommended in all women with polycystic ovary syndrome
Li, R., Lam, K. S. L., Tam, S., Lee, V. C. Y., Yeung, T. W. Y., Cheung, P. T., Yeung, W. S. B., Ho, P. C., & Ng, E. H. Y. (2015) · Human Reproduction · doi:10.1093/humrep/dev166 · Cited by 9
Family association study between tumour necrosis factor a gene polymorphisms and polycystic ovary syndrome in Han Chinese
Diao, X., Han, T., Zhang, Y., Ma, J., Shi, Y., & Chen, Z. (2014) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2014.07.005 · Cited by 9
Cardiovascular risk and combined oral contraceptives: clinical decisions in settings of uncertainty
Beller, J. P., & McCartney, C. R. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.01.037 · Cited by 9
How to Stay Heart Healthy in 2011: Considerations for the Primary Prevention of Cardiovascular Disease in Women
Davis, M. B., & Duvernoy, C. S. (2011) · Women s Health · doi:10.2217/whe.11.34 · Cited by 9

Authors: Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A.
Affiliations: OU Health (US)
University of Palermo (IT)
University of Athens Medical School (E.D.-K.), 11527 Athens, Greece
University of Pennsylvania (US)
Hospital Ramon y Cajal (H.F.E.-M.), 28034 Madrid, Spain
Icahn School of Medicine at Mount Sinai (US)
Columbia University (R.L.), New York, New York 10027
The University of Adelaide (AU)
University of Pittsburgh (US)
University of Wisconsin–Madison (US)
Corresponding author: Carmina, Enrico
ORCID: Wild, Robert A.
Carmina, Enrico
Dokras, Anuja
Norman, Robert J.
Talbott, Evelyn
Dumesic, Daniel A.
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2010-05-01
Volume: 95
Issue: 5
Pages: 2038-2049
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jc.2009-2724
OpenAlex: W2105749473
Semantic Scholar: 5556ce96457d5a9ef1f00894a9f61047e5c6afb4
Cited by: 1,010
References: 146
Citations by year: 2026: 34 · 2025: 47 · 2024: 45 · 2023: 62 · 2022: 77 · 2021: 52 · 2020: 56 · 2019: 73 · 2018: 61 · 2017: 58 · 2016: 62 · 2015: 89 · 2014: 85 · 2013: 69 · 2012: 62
FWCI: 79.63
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: polycystic ovary syndrome, cardiovascular risk, cardiovascular disease prevention, hyperandrogenism, obesity, dyslipidemia, hypertension, impaired glucose tolerance, metabolic syndrome, type 2 diabetes, subclinical vascular disease, body mass index, waist circumference, oral glucose tolerance test, mood disorders, lifestyle management, insulin-sensitizing drugs, cardiovascular risk assessment
MeSH terms: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Polycystic Ovary Syndrome, Risk Factors, Body Mass Index, Glucose Intolerance, Risk Assessment, Waist-Hip Ratio, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks